申请人:Aquinnah Pharmaceuticals, Inc.
公开号:US20200270211A1
公开(公告)日:2020-08-27
Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.